Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Banco Bilbao Vizcaya Argentaria SATrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Banco Bilbao Vizcaya Argentaria SA vs IDEXX Laboratories, Inc. — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $25.76 (market cap $142.30B), while IDEXX Laboratories, Inc. trades at $559.24 (market cap $42.65B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 3.3× IDEXX Laboratories, Inc.'s market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 4.2% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.

BBVAIDXX
Market Cap
$142.30B$42.65B
Sector
FinancialsHealth
52-Week High
$26.14$766.68
52-Week Low
$14.73$514.61
Dividend Yield
4.2%
Enterprise Value
$43.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Banco Bilbao Vizcaya Argentaria SA

No Aura AI signal available yet.

IDEXX Laboratories, Inc.

IDXX trades at $564.09, up 0.09% with neutral technical signals. The stock shows strong fundamentals with revenue growth to $4.3B in 2025 and consistent earnings beats. Analyst consensus is bullish (59% Buy) with improving cash flow trends. Recent news highlights AI integration in medical devices and upcoming Q2 2026 earnings.

Outlook remains positive driven by innovation and market leadership in pet healthcare. Risks include high valuation multiples and competitive pressures. Institutional sentiment supports growth, but investors should monitor execution against elevated expectations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Banco Bilbao Vizcaya Argentaria SA

Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.

Read more on BBVA

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX